{
  "id": "5a67c497b750ff4455000012",
  "type": "factoid",
  "question": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?",
  "ideal_answer": "Genomiser",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27569544"
  ],
  "snippets": [
    {
      "text": "Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases. Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Genomiser"
}